Filing Details

Accession Number:
0001209191-14-077958
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-24 13:58:55
Reporting Period:
2014-12-23
Filing Date:
2014-12-24
Accepted Time:
2014-12-24 13:58:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1037649 Interleukin Genetics Inc ILIU In Vitro & In Vivo Diagnostic Substances (2835) 943123681
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1288452 Bay City Capital Llc 750 Battery Street, Suite 400
San Francisco CA 94111
No No Yes No
1401826 Bay City Capital Fund V, L.p. 750 Battery Street, Suite 400
San Francisco CA 94111
No No Yes No
1409813 Bay City Capital Fund V Co-Investment Fund, L.p. 750 Battery Street, Suite 400
San Francisco CA 94111
No No Yes No
1461543 Bay City Capital Management V Llc 750 Battery Street, Suite 400
San Francisco CA 94111
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-12-23 25,996,552 $0.10 46,184,016 No 4 P Indirect See footnotes
Common Stock Acquisiton 2014-12-23 495,400 $0.10 880,099 No 4 P Indirect See footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnotes
No 4 P Indirect See footnotes
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrant (right to buy) Acquisiton 2014-12-23 25,996,552 $0.00 25,996,552 $0.10
Common Stock Common Stock Warrant (right to buy) Acquisiton 2014-12-23 495,400 $0.00 495,400 $0.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
25,996,552 2014-12-23 2021-12-23 No 4 P Indirect
495,400 2014-12-23 2021-12-23 No 4 P Indirect
Footnotes
  1. Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management V LLC, a Delaware limited liability company ("Management V"), Bay City Capital Fund V, L.P., a Delaware limited partnership ("Fund V"), and Bay City Capital Fund V Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment V"), are deemed to be a "group" for the purpose of Section 13(d) under the Securities Exchange Act of 1934. Management V is the general partner of Fund V and Co-Investment V and has sole voting and dispositive power with respect to the securities held by Fund V and Co-Investment V. BCC, the manager of Management V, is also an advisor to Fund V and Co-Investment V and has sole voting and dispositive power with respect to the securities held by Fund V and Co-Investment V.
  2. Represent securities held by Fund V, including indirect interests of Management V. Management V disclaims beneficial ownership with respect to these securities, except to the extent of its pecuniary interest therein.
  3. Represent securities held by Co-Investment V, including indirect interests of Management V. Management V disclaims beneficial ownership with respect to these securities, except to the extent of its pecuniary interest therein.